Skip to content

Clinical trials

Phase 3 Urinary Bladder, Neurogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Neurogenic Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20072
20111
20122
20151
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Pfizer2
APOGEPHA Arzneimittel GmbH1
Allergan1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier Universitaire Vaudois1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Rennes University Hospital1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Neurogenic13
Multiple Sclerosis2
Urinary Incontinence2
Urinary Tract Infections2
Urologic Diseases2
Bacterial Infections1
Bacteriuria1
Cystitis, Hemorrhagic1
Cystitis, Interstitial1
Endometriosis1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.